❭ Research by medical division ❭ Cancer Medicine ❭ Institute for Cancer Research ❭ Dept. of Cancer Immunology ❭ Immunotherapy against solid cancers [Kyte] ❭ News and Events ❭

Andreas Hagen Røssevold PhD defense

On February 9th, Andreas Hagen Røssevold triumphantly completed his PhD defense on "Immunotherapy and immunological biomarkers in breast cancer" at the OUH.
For more details on his groundbreaking research, read his recent publications on @NatureMedicine and ​​@jitcancer.

Public Defence: Andreas Hagen Røssevold ( med.uio.no)

 
Scroll to top

Home Dept. of Cancer Immunology Immunotherapy against solid cancers [Kyte]

  • Group members
  • Research projects
  • Publications
  • Available positions
  • News and Events

Recent publications

Ullern A, Holm K, Andresen NK, Røssevold AH, Bang C, Naume B, Hov JR, Kyte JA (2025)
Gut microbiota diversity is prognostic in metastatic hormone receptor-positive breast cancer patients receiving chemotherapy and immunotherapy
Mol Oncol (in press)
DOI 10.1002/1878-0261.70117, PubMed 40852937

Valsala Kumari R, Pandya AD, Pettersen SJ, Kvalvaag A, Myrann AG, Ghiarasim R, Rotaru A, Dimofte MG, Skotland T, Sandvig K, Mari Mælandsmo G, Iversen TG (2025)
Evaluation of HER2 Targeted Poly(Ethylene Glycol)-Poly(L-histidine) Copolymer Micelles in Breast Cancer Models
Macromol Biosci, e00047 (in press)
DOI 10.1002/mabi.202500047, PubMed 40719176

Singh R, Kyte JA (2025)
STEAP1: a promising target in prostate cancer therapy
Trends Cancer, 11 (8), 722-725
DOI 10.1016/j.trecan.2025.05.007, PubMed 40527692

More publications

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority.

Webmaster for research pages: Trond Olav Berg

Cookie policy

Accessibility statement (in Norwegian)